Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$839K Sell
6,531
-554
-8% -$64.8K 0.21% 73
2026
Q1
$852K Buy
7,085
+2,293
+48% +$265K 0.23% 75
2025
Q4
$504K Buy
+4,792
New +$450K 0.15% 97
2024
Q3
Sell
-1,957
Closed -$244K 134
2024
Q2
$244K Buy
1,957
+400
+26% +$51.5K 0.13% 112
2024
Q1
$205K Buy
+1,557
New +$192K 0.12% 116
2023
Q3
Sell
-1,945
Closed -$224K 107
2023
Q2
$224K Hold
1,945
0.15% 101
2023
Q1
$207K Sell
1,945
-289
-13% -$31.2K 0.17% 104
2022
Q4
$248K Buy
2,234
+1
+0% +$102 0.15% 103
2022
Q3
$192K Buy
+2,233
New +$199K 0.13% 109
2021
Q2
Sell
-1,003
Closed -$73K 255
2021
Q1
$73K Hold
1,003
0.04% 172
2020
Q4
$79K Buy
+1,003
New +$76.7K 0.06% 165

Other funds holding MRK

COWA LLC's MRK Position: Q2 2026 in Review

COWA LLC reduced its Merck (MRK) stake by 7.8% in Q2 2026, selling an estimated $64.8K and leaving 6,531 shares worth $839K. The position accounts for 0.21% of the portfolio, ranked #73.

COWA LLC first reported a position in MRK in Q4 2020 and has held it in 11 quarters since. The position peaked at $852K in Q1 2026. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • COWA LLC held 6,531 shares of Merck worth $839K as of Q2 2026.
  • COWA LLC sold 554 Merck shares in Q2 2026, an estimated $64.8K.
  • Merck made up 0.21% of COWA LLC's portfolio in Q2 2026, its #73 holding.
  • COWA LLC first reported a position in Merck in Q4 2020 and has held it in 11 quarters since.
  • COWA LLC's Merck position peaked at $852K in Q1 2026.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on COWA LLC's 13F filing for Q2 2026, filed 6 Aug 2026.